These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15172355)

  • 1. Expression of epidermal growth-factor receptor in lymphangiomatosis: a new therapeutic target?
    Mertsching H; Walles T; Bakker G; Wildfang I; Macchiarini P
    Lancet Oncol; 2004 Jun; 5(6):353. PubMed ID: 15172355
    [No Abstract]   [Full Text] [Related]  

  • 2. Mediastinal lymphangiomatosis coexisting with occult thymic carcinoma.
    Ikeda J; Morii E; Tomita Y; Zhang B; Tokunaga T; Inoue M; Minami M; Okumura M; Aozasa K
    Virchows Arch; 2007 Feb; 450(2):211-4. PubMed ID: 17120029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alpha 2b treatment in an eleven-year-old boy with disseminated lymphangiomatosis.
    Timke C; Krause MF; Oppermann HC; Leuschner I; Claviez A
    Pediatr Blood Cancer; 2007 Jan; 48(1):108-11. PubMed ID: 16007599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of multiple lymphangiomas of the colon suggesting colonic lymphangiomatosis.
    Watanabe T; Kato K; Sugitani M; Hasunuma O; Sawada T; Hoshino N; Kaneda N; Kawamura F; Arakawa Y; Hirota T
    Gastrointest Endosc; 2000 Dec; 52(6):781-4. PubMed ID: 11115919
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pluritopic hemangiolymphangioma in a young woman].
    Duda M; Jezdinská V; Oral I; Fargas E
    Zentralbl Chir; 1980; 105(14):927-31. PubMed ID: 7467911
    [No Abstract]   [Full Text] [Related]  

  • 6. Growth factor receptor expression in orbital lymphangioma: possible therapeutic implications.
    Esmaeli B; Prieto VG; Gonnering R; Hawes MJ; Diba R; Saadati HG; Shepler TR; Karcioglu Z
    Orbit; 2004 Dec; 23(4):263-9. PubMed ID: 15590529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of mediastinal lymphangioma successfully treated with Kampo medicine.
    Ogawa-Ochiai K; Sekiya N; Kasahara Y; Chino A; Ueda K; Kimata Y; Yamamoto S; Okimoto Y; Higashimoto H; Namiki T; Terasawa K
    J Altern Complement Med; 2011 Jun; 17(6):563-5. PubMed ID: 21568721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blunt thoracic trauma with hemorrhage into a mediastinal lymphangioma--case report].
    Menth M; Balmer MC; Ris HB
    Swiss Surg; 1998; 4(2):58-60. PubMed ID: 9587229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant cystic lymphangioma of the mediastinum.
    Bossert T; Gummert JF; Mohr FW
    Eur J Cardiothorac Surg; 2002 Feb; 21(2):340. PubMed ID: 11825749
    [No Abstract]   [Full Text] [Related]  

  • 10. Mediastinal and osseous lymphangiomatosis: case report and review.
    Watts MA; Gibbons JA; Aaron BL
    Ann Thorac Surg; 1982 Sep; 34(3):324-8. PubMed ID: 7114951
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphangioma-like Kaposi's sarcoma with gastric involvement in a patient with lung cancer.
    Kalambokis G; Kitsanou M; Stergiopoulou C; Zioga A; Dimou S; Tsianos EV
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):653-4. PubMed ID: 16164738
    [No Abstract]   [Full Text] [Related]  

  • 12. Human epidermal growth factor receptor 2 testing in breast cancer: 30% versus 10% cutoff for immunohistochemistry.
    Hameed O; Chhieng D; Adams AL
    J Clin Oncol; 2008 Mar; 26(9):1571. PubMed ID: 18349417
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma.
    Gotoh M; Takiuchi H; Kawabe S; Ohta S; Kii T; Kuwakado S; Katsu K
    Jpn J Clin Oncol; 2007 Sep; 37(9):652-7. PubMed ID: 17940077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic hemangiomatosis and lymphangiomatosis].
    Kostov M; Tatić V; Cerović S; Skatarić V; Bjelajac D
    Vojnosanit Pregl; 1997; 54(4):391-3. PubMed ID: 9441510
    [No Abstract]   [Full Text] [Related]  

  • 15. Sudden death of a 14-year-old girl with lymphangiomatosis.
    Nakagawa T; Koizumi T; Oiwa K; Inomoto C; Ogura G; Masuda R; Yamashita T; Nakamura N; Iwazaki M
    Gen Thorac Cardiovasc Surg; 2016 Feb; 64(2):116-9. PubMed ID: 25047633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ongoing osteolysis in patients with lymphangioma.
    Ogita S; Deguchi E; Tokiwa K; Iwata J; Kubota Y; Iwai N
    J Pediatr Surg; 1998 Jan; 33(1):45-8. PubMed ID: 9473098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postchemotherapy-related changes in mediastinal mixed germ cell tumor masquerading as a vascular neoplasm.
    Hui M; Tandon A; Uppin SG; Paruchuri RK
    Indian J Pathol Microbiol; 2012; 55(4):531-4. PubMed ID: 23455797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-systemic diffuse lymphangiomatosis of spleen and liver.
    Schmid C; Beham A; Uranüs S; Melzer G; Auböck L; Seewann HL; Klimpfinger M
    Histopathology; 1991 May; 18(5):478-80. PubMed ID: 1885170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidermal growth factor receptor as a prognostic factor of breast cancers].
    Tsutsui S
    Nihon Rinsho; 2000 Apr; 58 Suppl():442-7. PubMed ID: 11026031
    [No Abstract]   [Full Text] [Related]  

  • 20. Gefitinib in pretreated non-small-cell lung cancer (NSCLC): analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLC.
    Cappuzzo F; Gregorc V; Rossi E; Cancellieri A; Magrini E; Paties CT; Ceresoli G; Lombardo L; Bartolini S; Calandri C; de Rosa M; Villa E; Crino L
    J Clin Oncol; 2003 Jul; 21(14):2658-63. PubMed ID: 12860941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.